Dextech Medical AB reported earnings results for the fourth quarter and full year ended June 30, 2022. For the fourth quarter, the company reported sales was SEK 2.89 million compared to SEK 0.164 million a year ago. Net loss was SEK 2.06 million compared to SEK 1.49 million a year ago. Basic loss per share from continuing operations was SEK 0.11 compared to SEK 0.1 a year ago.
For the full year, sales was SEK 3.12 million compared to SEK 0.635 million a year ago. Net loss was SEK 5.27 million compared to SEK 6.08 million a year ago. Basic loss per share from continuing operations was SEK 0.31 compared to SEK 0.41 a year ago.